HOEMANN, MICHAEL Z.,WISHART, NEIL,ARGIRIADI, MARIA A.,BREINLINGER, ERIC C.,CALDERWOOD, DAVID J.,ERICSSON, ANNA M.,FIAMENGO, BRYAN A.,FRANK, KRISTINE E.,FRIEDMAN, MICHAEL,GEORGE, DAWN M.,GOEDKEN, ERIC
申请号：
SG2012039905
公开号：
SG181147A1
申请日:
2010.12.01
申请国别(地区):
SG
年份:
2012
代理人:
摘要：
The invention provides a compound of Formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (Ii), (Ij), (Ik), or (Il) as defined herein, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
